vadinamu sulfonilkarbamidu, arba

called a sulphonylurea, or 25

KARTU SU METFORMINU IR SULFONILKARBAMIDU

PIOGLITAZONE IN TRIPLE ORAL COMBINATION THERAPY WITH METFORMIN AND SULPHONYLUREA

PIOGLITAZONAS, VARTOJAMAS KARTU SU SULFONILKARBAMIDU

PIOGLITAZONE IN COMBINATION THERAPY WITH SULPHONYLUREA

PIOGLITAZONO, VARTOJAMO KARTU SU SULFONILKARBAMIDU

General disorders and administration site conditions

PIOGLITAZONO, VARTOJAMO KARTU SU SULFONILKARBAMIDU
http://www.emea.europa.eu/

PIOGLITAZONE IN COMBINATION THERAPY WITH SULPHONYLUREA
http://www.emea.europa.eu/

PIOGLITAZONO, VARTOJAMO KARTU SU SULFONILKARBAMIDU Ausies ir labirinto sutrikimai

PIOGLITAZONE IN COMBINATION THERAPY WITH SULPHONYLUREA Ear and labyrinth disorders

PIOGLITAZONO, VARTOJAMO KARTU SU SULFONILKARBAMIDU Ausies ir labirinto sutrikimai

Common:erectile dysfunctionPIOGLITAZONE IN COMBINATION THERAPY WITH SULPHONYLUREA Ear and labyrinth disorders

· vaisto skiriama kartu su sulfonilkarbamidu pacientams, kuri gydymas vien sulfonilkarbamidu

· in combination with a sulphonylurea in patients who are not satisfactorily controlled with a

Dazni:erekcijos funkcijos sutrikimas.PIOGLITAZONO, VARTOJAMO KARTU SU SULFONILKARBAMIDU

PIOGLITAZONE IN COMBINATION THERAPY WITH SULPHONYLUREA

Galima kryžminė alerginė reakcija su sulfonilkarbamidu, sulfonamidais ar panašiais dariniais.
http://www.emea.europa.eu/

Cross allergenicity with sulphonylureas, sulphonamides or related substances is possible.
http://www.emea.europa.eu/

Galima kryzmin alergin reakcija su sulfonilkarbamidu, sulfonamidais ar panasiais dariniais.

Cross allergenicity with sulphonylureas, sulphonamides or related substances is possible.

Mazdaug trecdalis pacient insulin vartojo kartu su metforminu ir (arba) sulfonilkarbamidu.

Approximately one third of patients were receiving insulin in combination with metformin and/or a sulphonylurea.

- sulfonilkarbamidu, tik tų pacientų, kurie netoleruoja metformino arba kuriems yra jo vartojimo
http://www.emea.europa.eu/

- a sulphonylurea, only in patients who show intolerance to metformin or for whom metformin is
http://www.emea.europa.eu/

Maždaug trečdalis pacientų insuliną vartojo kartu su metforminu ir (arba) sulfonilkarbamidu.
http://www.emea.europa.eu/

Approximately one third of patients were receiving insulin in combination with metformin and/ or a sulphonylurea.
http://www.emea.europa.eu/

- sulfonilkarbamidu, tik tų pacientų, kurie netoleruoja metformino arba kuriems yra jo vartojimo
http://www.emea.europa.eu/

- a sulphonylurea, only in patients who show intolerance to metformin or for whom
http://www.emea.europa.eu/

-metforminu ir sulfonilkarbamidu, pacient (ypac turinci antsvorio) tuo atveju, jeigu gydymo

-metformin and a sulphonylurea, in patients (particularly overweight patients) with insufficient

· vaisto skiriama kartu su metforminu ir sulfonilkarbamidu, kai diabetu serganci pacient gydymas

· in combination with both metformin and a sulphonylurea, when both medicines are not sufficient

Nustatyta, kad doksiciklinas sustiprina geriamųjų vaistų nuo diabeto su sulfonilkarbamidu hipoglikeminį poveikį.
http://www.emea.europa.eu/

Doxycycline has been shown to potentiate the hypoglycaemic effect of sulphonylurea oral antidiabetic agents.
http://www.emea.europa.eu/

Kai kuriems pacientams, vartojusiems Jalra kartu su sulfonilkarbamidu, pasireiškė šis šalutinis poveikis:
http://www.emea.europa.eu/

Some patients have had the following side effects while taking Jalra and a sulphonylurea:  Common:
http://www.emea.europa.eu/

Kai kuriems pacientams, vartojusiems Galvus kartu su sulfonilkarbamidu, pasireisk sis salutinis poveikis:

Some patients have had the following side effects while taking Galvus and a sulphonylurea: